Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shima Mimura

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Internal Medicine (Tokyo, Japan)|May 29, 2024
Chronic Hepatitis B in Which HBs Antigen Seroclearance Was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-upShima Mimura, Masafumi Ono, Koji Fujita, et al.
Geriatrics (Basel, Switzerland)|April 27, 2026
Constipation in Older Adults: Pathophysiology, Clinical Impact, and Management StrategiesShima Mimura, Asahiro Morishita, Atsuo Kitaoka, et al.
Journal of Gastroenterology|April 3, 2025
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinomaKyoko Oura, Asahiro Morishita, Rie Yano, et al.
International Journal of Molecular Sciences|February 15, 2022
Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell LinesKei Takuma, Shintaro Fujihara, Koji Fujita, et al.
European Journal of Gastroenterology & Hepatology|September 14, 2020
L-carnitine reduces hospital admissions in patients with hepatic encephalopathyJoji Tani, Asahiro Morishita, Teppei Sakamoto, et al.
World Journal of Hepatology|July 31, 2013
A rare case of hyaline-type Castleman disease in the liverHisaaki Miyoshi, Shima Mimura, Takako Nomura, et al.
Internal Medicine (Tokyo, Japan)|January 18, 2021
Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-upTomoko Tadokoro, Koji Fujita, Kei Takuma, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 14, 2025
Do Patients With Alcoholic Cirrhosis Accurately Recognize Their Alcohol Tolerance? A Study Comparing Self-Perception and ALDH2/ADH1B GenotypeTomoko Tadokoro, Mai Nakahara, Hiroki Tai, et al.
Anticancer Research|September 26, 2025
Antitumor Potential of Epigallocatechin Gallate in Overcoming Molecular Therapy Resistance in Hepatocellular CarcinomaAtsuo Kitaoka, Kyoko Oura, Koji Fujita, et al.
Scientific Reports|May 11, 2024
Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosisTomoko Tadokoro, Joji Tani, Takushi Manabe, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Internal Medicine (Tokyo, Japan)|May 29, 2024
Chronic Hepatitis B in Which HBs Antigen Seroclearance Was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-upShima Mimura, Masafumi Ono, Koji Fujita, et al.
Geriatrics (Basel, Switzerland)|April 27, 2026
Constipation in Older Adults: Pathophysiology, Clinical Impact, and Management StrategiesShima Mimura, Asahiro Morishita, Atsuo Kitaoka, et al.
Journal of Gastroenterology|April 3, 2025
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinomaKyoko Oura, Asahiro Morishita, Rie Yano, et al.
International Journal of Molecular Sciences|February 15, 2022
Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell LinesKei Takuma, Shintaro Fujihara, Koji Fujita, et al.
European Journal of Gastroenterology & Hepatology|September 14, 2020
L-carnitine reduces hospital admissions in patients with hepatic encephalopathyJoji Tani, Asahiro Morishita, Teppei Sakamoto, et al.
World Journal of Hepatology|July 31, 2013
A rare case of hyaline-type Castleman disease in the liverHisaaki Miyoshi, Shima Mimura, Takako Nomura, et al.
Internal Medicine (Tokyo, Japan)|January 18, 2021
Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-upTomoko Tadokoro, Koji Fujita, Kei Takuma, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 14, 2025
Do Patients With Alcoholic Cirrhosis Accurately Recognize Their Alcohol Tolerance? A Study Comparing Self-Perception and ALDH2/ADH1B GenotypeTomoko Tadokoro, Mai Nakahara, Hiroki Tai, et al.
Anticancer Research|September 26, 2025
Antitumor Potential of Epigallocatechin Gallate in Overcoming Molecular Therapy Resistance in Hepatocellular CarcinomaAtsuo Kitaoka, Kyoko Oura, Koji Fujita, et al.
Scientific Reports|May 11, 2024
Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosisTomoko Tadokoro, Joji Tani, Takushi Manabe, et al.
Pageof 6